Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?

Is Congress Poised to Deal a Significant Blow to Hatch-Waxman and the Generic Drug Industry?

Source: 
FDA Law Blog
snippet: 

Earlier this week, House Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ), Ranking Member Greg Walden (R-OR) and Senate Health Committee Chairman Lamar Alexander (R-TN) announced that they reached agreement on a bipartisan, bicameral drug pricing bill, called The Lower Health Care Costs Act of 2019.